Science Current Events | Science News | Brightsurf.com
 

Many patients continue using opioids months after joint replacement

June 01, 2016

Many patients undergoing hip or knee replacement are still taking prescription opioid pain medications up to six months after surgery, reports a study in PAIN®, the official publication of the International Association for the Study of Pain® (IASP). The journal is published by Wolters Kluwer.

Led by Jenna Goesling, PhD, of the University of Michigan, the study identifies several "red flags" for persistent opioid use--particularly previous use of high-dose opioids. The results also suggest that some patients continue to use these potentially addictive pain medications despite improvement in their hip or knee pain.

Concerns about Persistent Opioid Use after Joint Replacement

Total knee and hip replacements are highly effective operations for patients with severe pain in these joints, and opioids are the main drugs used for acute pain management after such surgeries. However, little is known about long-term patterns of opioid use after joint-replacement surgery. This information is especially important as such surgeries become even more frequent as the US population ages and the "opioid epidemic" continues to produce dramatic increases in opioid use, misuse, and overdose.

Dr. Goesling and her team analyzed patterns of opioid use in 574 patients undergoing knee or hip replacement surgery (arthroplasty). Patients were followed up at one, three, and six months after surgery to assess rates of and risk factors for long-term opioid use.

About 30 percent of the patients were taking opioids prior to their joint replacement surgery. Of this group, 53 percent of knee-replacement patients and 35 percent of hip replacement patients were still taking opioids at six months after surgery.

Patients who were not taking opioids prior to surgery were less likely to report persistent opioid use: About 8 percent in the knee-replacement group and 4 percent in the hip-replacement group continued to take opioids at the six-month follow up. Although these are relatively small percentages, this suggests that a portion of patients who were "opioid naĂ-ve" prior to surgery will become new chronic opioid users following arthroplasty.

The strongest predictor of long-term opioid use was taking high-dose opioids before joint replacement surgery. For patients in the highest preoperative dose group (equivalent to more than 60 milligrams of oral morphine per day), the predicted probability of persistent opioid use at six months was 80 percent.

Among patients not previously taking opioids, those with higher pain scores the day of surgery--both in the affected joint and overall body pain--were more likely to report persistent opioid use at six months. Opioid use was also more likely for patients who scored higher on a measure of pain catastrophizing--exaggerated responses and worries about pain--than those with depressive symptoms.

For all patients, reductions in overall body pain were associated with decreased odds of being on opioids at six months. However, improvement in knee or hip pain after joint replacement did not reduce the likelihood of long-term opioid use.

Persistent opioid use after knee or hip replacement surgery may be more common than previously reported, the new results suggest. Importantly, continued opioid use is not necessarily related to pain in the affected joint. "We hypothesize that the reasons patients continue to use opioids may be due to pain in other areas, self-medicating affective distress, and therapeutic opioid dependence," the researchers write.

Dr. Goesling and coauthors discuss the implications for short-term and long-term pain management for patients undergoing joint replacement surgery. They add, "A long-term goal includes the development of interventions to aid physicians and patients with opioid cessation following surgical interventions" such as hip and knee replacement.

###

Click here to read "Trends and predictors of opioid use after total knee and total hip arthroplasty."

Article: "Trends and predictors of opioid use after total knee and total hip arthroplasty" (doi: 10.1097/j.pain.0000000000000516)

About PAIN

PAIN is IASP's official journal. Published monthly, PAIN presents original research on the nature, mechanisms, and treatment of pain. Available to IASP members as a membership benefit, this peer-reviewed journal provides a forum for the dissemination of multidisciplinary research in the basic and clinical sciences. It is cited in Current Contents and Index Medicus.

About the International Association for the Study of Pain

IASP is the leading professional organization for science, practice, and education in the field of pain. Membership is open to all professionals involved in research, diagnosis, or treatment of pain. IASP has more than 7,000 members in 133 countries, 90 national chapters, and 20 special interest groups (SIGs). IASP brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain and translate that knowledge into improved pain relief worldwide.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit http://www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Wolters Kluwer Health


Related Opioids Current Events and Opioids News Articles


Pharmacist prescribes education as key to curbing opioid abuse
Technologies that make it harder for people to abuse opioids - like doctoring pills so that they produce unpleasant side effects if broken, crushed or injected -- likely will have limited effectiveness in stemming the global epidemic of opioid abuse, according to Adam Kaye, a professor of pharmacy at University of the Pacific.

Antidote to opioid drug overdoses could become more accessible
Over the past 15 years, deaths caused by heroin and prescription opioid overdoses have quadrupled despite the existence of a highly effective antidote.

Poll: Many parents keep prescription opioids at home
Nearly half of parents whose child had leftover pain medication from a surgery or illness say they kept the prescription opioids at home -- representing a potential problem down the line.

Research findings reveal potential to reverse cancer-related nerve pain
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.

Researchers identify sharp rise in opioid-related hospitalizations, health care costs
Infection is a serious complication of intravenous drug abuse and a major cause of illness and death among intravenous drug users.

Expand prescribing of buprenorphine for opioid abuse? Experts weigh pros and cons
Buprenorphine is a critical part of treatment for the growing epidemic of opioid abuse--but also carries the potential for misuse and diversion.

Standardizing care improves outcomes for infants born with neonatal abstinence syndrome
Standardizing hospital care policies across institutions for infants diagnosed with drug withdrawal symptoms at birth reduces their length of treatment and hospitalization, according to new collaborative research led by Vermont Oxford Network, Vanderbilt and the University of Michigan Health System.

Results of world's first study on new treatment for heroin addiction
The results of the ground-breaking SALOME research, published in the Journal of the American Medical Association (JAMA) Psychiatry, show chronic heroin addiction now has another effective treatment tool - hyrdomorphone, a licensed pain medication.

Take-home naloxone should be an additional standard of care for prevention of heroin overdose death
Death from opioid overdose is preventable through timely administration of the antidote naloxone. Several countries now provide take-home naloxone (THN) to opioid users for emergency use, but mostly as pilot schemes and without formal evaluation.

New international research reinforces the link between public policy and life expectancy
While average life expectancy has been rising steadily in most countries over the past century, new research led by the Centre for Addiction and Mental Health (CAMH) shows that life expectancy declined significantly and rapidly in three countries where policy changes increased access to prescription opioids, alcohol or illicit drugs.
More Opioids Current Events and Opioids News Articles

The Opioid Epidemic: Narcotics, Heroin, Pill Mills, Painkiller Addiction, Medical Prescribing Practice for Pain Management, Child Welfare, Neonatal Abstinence Syndrome (NAS), Naloxone, Narcan

The Opioid Epidemic: Narcotics, Heroin, Pill Mills, Painkiller Addiction, Medical Prescribing Practice for Pain Management, Child Welfare, Neonatal Abstinence Syndrome (NAS), Naloxone, Narcan
by U.S. Government (Author)


This unique collection provides comprehensive information on the ongoing opioid addiction epidemic. Contents include: Examining the Opioid Epidemic * Combating the Opioid Abuse Epidemic: Professional and Academic Perspectives * What Are the State Governments Doing to Combat the Opioid Abuse Epidemic? * What is the Federal Government Doing to Combat the Opioid Abuse Epidemic? * Obama Administration Announces Additional Actions to Address the Prescription Opioid Abuse and Heroin Epidemic Opioids are a powerful class of drugs prescribed to treat severe pain. When used appropriately, these drugs provide much needed relief to patients after a surgical procedure or during treatment for cancer. Unfortunately, opioids also have qualities that make them addictive and prone to abuse. The goal of...

The Opioid-Free Pain Relief Kit: 10 Simple Steps to Ease Your Pain

The Opioid-Free Pain Relief Kit: 10 Simple Steps to Ease Your Pain
by Beth Darnall PhD (Author)


CONGRATULATIONS! Picking up this book shows you want to help yourself feel better. That’s the first step toward having less pain and using less pain medication. You are not alone. About 100 million Americans—one in three people—have ongoing pain. It can be mild or very strong, come in waves or always be present, be simply annoying or make your normal life hard to live. Pain is the most common reason people visit their doctor. Many people mistakenly believe that chronic pain is best treated simply by taking powerful painkillers, also known as opioids. But people who think pills are the only answer are mistaken, because the best treatment for chronic pain includes much more than pills. In fact, the most important part of pain treatment isn’t your medication or even your doctor:...

Opioid Therapy in the 21st Century (Oxford American Pain Library)

Opioid Therapy in the 21st Century (Oxford American Pain Library)
by Howard S. Smith (Author)


Over the last thirty years, the concern of Pain Medicine practitioners about the potential for their patients to develop a dependence on opioids has left opioid therapy as a largely underutilized treatment. While there is no simple answer to chronic pain, opioids remain the only class of drugs capable of providing relief to patients experiencing serious pain. Opioid Therapy in the 21st Century, Second Edition fills a dearth of clinical knowledge about analgesics to aid practitioners in weighing the risks versus the benefits of opioid therapy for their chronic pain patients. This second edition provides updated information on recently approved opioids as well as approved indications for older opioids and clinical trials.

Part of the Oxford American Pain Library, this concise guide...

Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing (McPherson, Demystifying Opioid Conversion Calculations)

Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing (McPherson, Demystifying Opioid Conversion Calculations)
by Mary Lynn McPherson (Author)


Have you ever wondered if you calculated your patient’s dosage correctly? Against a backdrop of the growing scrutiny of appropriate dosages, this textbook takes a fresh, new approach to helping health professionals strengthen care to and possibly save the lives of patients living with pain. This easy-to-understand and often humorous book is the most comprehensive to-date on opioid calculations for pain management and palliative care. It carefully walks clinicians through a five-step process for performing opioid conversion calculations in the real-world situations they often see. The book has case examples, simple charts and tables, and practice problems throughout on topics such as:·         difficult conversions for methadone, fentanyl, PCA, and neuraxial opioid...

Dreamland: The True Tale of America's Opiate Epidemic

Dreamland: The True Tale of America's Opiate Epidemic
by Sam Quinones (Author)


Winner of the NBCC Award for General Nonfiction

Named on Amazon's Best Books of the Year 2015--Michael Botticelli, U.S. Drug Czar (Politico) Favorite Book of the Year--Angus Deaton, Nobel Prize Economics (Bloomberg/WSJ) Best Books of 2015--Matt Bevin, Governor of Kentucky (WSJ) Books of the Year--Slate.com’s 10 Best Books of 2015--Entertainment Weekly’s 10 Best Books of 2015 --Buzzfeed’s 19 Best Nonfiction Books of 2015--The Daily Beast’s Best Big Idea Books of 2015--Seattle Times’ Best Books of 2015--Boston Globe’s Best Books of 2015--St. Louis Post-Dispatch’s Best Books of 2015--The Guardian’s The Best Book We Read All Year--Audible’s Best Books of 2015--Texas Observer’s Five Books We Loved in 2015--Chicago Public Library’s Best Nonfiction Books of 2015From...

Opioid Use Disorder

Opioid Use Disorder
by NetCE


The purpose of this course is to assist healthcare professionals in identifying, treating, and providing appropriate referrals to patients with opioid use disorders. Fear of creating new opioid addicts has influenced prescribing practices for decades, and this course will convey the actual risk of patient addiction to these pain-relieving drugs when used legitimately. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.

Upon completion of this course, you should be able to:

1. Define key terms associated with opioid abuse and dependence.
2. Outline the background and epidemiology of opioid use and abuse, including risk factors for misuse and dependence.
3. Describe the pharmacology and...

Handbook of Office-based Buprenorphine Treatment of Opioid Dependence

Handbook of Office-based Buprenorphine Treatment of Opioid Dependence
by John A. Renner (Author), Petros Levounis (Author)


The Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence will serve as a reliable guide for the addition of buprenorphine treatment into existing psychiatric practices and other primary care settings. The potential to improve the lives of patients with the disease of opioid addiction is great, and this book offers concrete and practical advice for managing patients in an office-based setting. Distinguished practicing psychiatrists, internists, and other clinical experts and researchers contribute their expertise with buprenorphine to this volume. It covers the subject matter thoroughly from the history of opioid abuse and assessment criteria for potential patients to clinical management and psychiatric comorbidity. This handbook provides the tools and guidelines...

Community Solutions to Breaking the Cycle of Heroin and Opioid Addiction

Community Solutions to Breaking the Cycle of Heroin and Opioid Addiction
by Committee on the Judiciary United States Senate (Author)


The heroin and opioid crisis is a complex challenge. It goes into neighborhoods, it goes into communities of all kinds and sizes, in urban and rural areas alike throughout the country. The state of Vermont has not been spared. Since 2012, demand for addiction treatment in Vermont has risen by more than 770 percent. The situation in Vermont is consistent with what is occurring around the country. There are numerous stories of young people whose lives have either been ruined or ended because of their addiction. It is not possible to arrest our way out of this problem. It is not just a law enforcement problem. Prevention, education, and treatment must be employed along with law enforcement. Furthermore, the criminal justice system on the federal level can learn from local systems. When we...

Heroin Death: How to Stop the Opioid Crisis

Heroin Death: How to Stop the Opioid Crisis
by Joseph C Mancini MD (Author)


We find ourselves in the worst epidemic in United States history! Sudden, accidental death from heroin has quadrupled since 1999! Prescriptions for pain medication (often known as narcotics) has quadrupled since 1999! This is not a coincidence. Heroin and narcotic pain pills are chemically very similar, and both are OPIOIDS! Together, they now cause more deaths than gunshot wounds in this country and almost as many deaths due to motor vehicle accidents! In this concise booklet, Dr. Mancini explains why we are in this crisis and offers 3 strategies to stop the epidemic and drastically decrease this deadly upward trend that we are experiencing in this nation!

Opioid-Induced Hyperalgesia

Opioid-Induced Hyperalgesia
by Jianren Mao (Editor)


The first clinically focused text dedicated to the newly emerging area of pain medicine known as opioid-induced hyperalgesia (OIH), Opioid-Induced Hyperalgesia provides pain specialists, anesthesiologists, and neurologists with the most current, cutting-edge research and therapeutic options for treating OIH patients. It supplies best practice guidelines for the effective assessment, diagnosis, and management of OIH―need-to-know information clinicians trust and can use in their practice.

Organized to provide the information quickly and easily, the book includes dosage recommendations to help minimize the likelihood and/or delay onset of hyperglasia and covers management approaches such as opioid rotation and tapering, provide clinicians with alternative methods for treating OIH's...

© 2017 BrightSurf.com